Positron emission tomography (PET) is a novel non invasive functional imaging modality that is increasingly used for the primary staging of lymphomas and assessment of therapeutic response. This review evaluates the published reports of its use in childhood lymphomas, particularly in the primary staging, response assessment and monitoring after completion of treatment. Specific attention is focused on the clinical circumstances in which FDG PET is most likely to have an impact on management and some indications for its use in childhood lymphomas are suggested
In the present review the reader will be led across the most relevant observations that prompted onc...
We performed an observational pilot study of 18F-FLT PET/CT in pediatric lymphoma. Eight patients wi...
Lymphomas are a heterogeneous group of diseases that arise from the constituent cells of the immune ...
The usefulness of 18F fluorodeoxyglucose (FDG) positron emission tomography (PET) in pediatric Hodgk...
Positron emission tomography (PET) is a sectional molecular imaging procedure taht allows evaluation...
Aim of work: To evaluate the sensitivity (Se), specificity (Sp), and predictive values (PV) of PET s...
Within recent years, F-18 fluorodeoxyglucose (FDG) PET has become the most important nuclear medicin...
International audience18F-fluorodeoxyglucose positron emission tomography combined with computed tom...
Positron emission tomography (PET) with fluorine-18 labeled deoxyglucose (FDG) is useful in the mana...
Positron emission tomography (PET) using fluorine-18 (FDG) is increasingly used in the staging of ly...
AbstractAim of workTo evaluate the sensitivity (Se), specificity (Sp), and predictive values (PV) of...
Most non-Hodgkin lymphomas (NHL) are of B-cell origin; only about 10% are T-cell or NK-cell lymphoma...
PET/CT using (18)F-FDG is an essential part of the management of patients with lymphoma. Efforts to ...
Abbreviated title: FDG-PET for pediatric NHL No financial disclosure. No conflict of interest 2 Purp...
The clinical use of PET and PET/CT aids physicians and patients in developing lymphoma prognoses, sp...
In the present review the reader will be led across the most relevant observations that prompted onc...
We performed an observational pilot study of 18F-FLT PET/CT in pediatric lymphoma. Eight patients wi...
Lymphomas are a heterogeneous group of diseases that arise from the constituent cells of the immune ...
The usefulness of 18F fluorodeoxyglucose (FDG) positron emission tomography (PET) in pediatric Hodgk...
Positron emission tomography (PET) is a sectional molecular imaging procedure taht allows evaluation...
Aim of work: To evaluate the sensitivity (Se), specificity (Sp), and predictive values (PV) of PET s...
Within recent years, F-18 fluorodeoxyglucose (FDG) PET has become the most important nuclear medicin...
International audience18F-fluorodeoxyglucose positron emission tomography combined with computed tom...
Positron emission tomography (PET) with fluorine-18 labeled deoxyglucose (FDG) is useful in the mana...
Positron emission tomography (PET) using fluorine-18 (FDG) is increasingly used in the staging of ly...
AbstractAim of workTo evaluate the sensitivity (Se), specificity (Sp), and predictive values (PV) of...
Most non-Hodgkin lymphomas (NHL) are of B-cell origin; only about 10% are T-cell or NK-cell lymphoma...
PET/CT using (18)F-FDG is an essential part of the management of patients with lymphoma. Efforts to ...
Abbreviated title: FDG-PET for pediatric NHL No financial disclosure. No conflict of interest 2 Purp...
The clinical use of PET and PET/CT aids physicians and patients in developing lymphoma prognoses, sp...
In the present review the reader will be led across the most relevant observations that prompted onc...
We performed an observational pilot study of 18F-FLT PET/CT in pediatric lymphoma. Eight patients wi...
Lymphomas are a heterogeneous group of diseases that arise from the constituent cells of the immune ...